2022
DOI: 10.1097/md.0000000000029928
|View full text |Cite
|
Sign up to set email alerts
|

STROBE-GnRHa pretreatment in frozen-embryo transfer cycles improves clinical outcomes for patients with persistent thin endometrium: A case-control study

Abstract: The well-prepared endometrium with appropriate thickness plays a critical role in successful embryo implantation. The thin endometrium is the main factor of frozen-embryo transfer (FET), resulting in the failure of implantation undergoing FET. Hormone treatment is suggested to improve endometrium thickness; however, among the larger numbers of cases, it cannot reach the sufficient thickness, which leads to a high cancelation rate of embryo transfer as well as waste high-quality embryos. Thus, it increases the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…Previous studies suggested that the pre-treatment of long-acting GnRHa was conducive to the establishment of endometrial receptivity, and the endometrial receptivity of long-acting GnRHa IVF cycle is better than that of short-acting GnRHa IVF cycle. 27,28 We speculate that this may be the possible reason for the different predicted P cut-off values of these two COH protocols. Cleavage-stage embryos transfer has certain advantages in short-acting GnRHa IVF-ET cycles.…”
Section: Discussionmentioning
confidence: 95%
“…Previous studies suggested that the pre-treatment of long-acting GnRHa was conducive to the establishment of endometrial receptivity, and the endometrial receptivity of long-acting GnRHa IVF cycle is better than that of short-acting GnRHa IVF cycle. 27,28 We speculate that this may be the possible reason for the different predicted P cut-off values of these two COH protocols. Cleavage-stage embryos transfer has certain advantages in short-acting GnRHa IVF-ET cycles.…”
Section: Discussionmentioning
confidence: 95%
“…GnRH-a drugs are the first-line of clinical use in assisted reproduction and endometriosis. After the first application of GnRH-a, it binds to the GnRH receptor in the pituitary gland and instantly stimulates the release of gonadotropins (follicle stimulating hormone and luteinizing hormone) from pituitary cells, resulting in a ‘flare-up’ effect, which raises the serum estrogen level and stimulates the body to produce the cytokines necessary for implantation, thus improving the EMT and increasing endometrial tolerance ( 31 ). GnRH-a in combination with human menopausal gonadotropin also enhances the stimulation of follicular development and improves EMT in women undergoing FET after intensified estrogen administration ( 32 ).…”
Section: Te Treatmentsmentioning
confidence: 99%
“…For the different endometrial preparation protocols commonly used, studies have shown that there is no significant difference in the HRT cycle or GnRHa-HRT cycle and the latter protocol increases the cost of treatment ( 12 , 13 ). On the contrary, studies have also shown that GnRHa-HRT effectively improved clinical pregnancy ( 14 ) and live birth rates ( 15 ). Based on the results of the above studies, some controversies about the advantages and disadvantages of the HRT cycle or GnRHa-HRT cycle in endometrial preparation protocols still exist.…”
Section: Introductionmentioning
confidence: 99%